Apollon Wealth Management »

Abcellera Biologics shares owned by Apollon Wealth Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Apollon Wealth Management from 13F filings

Historical chart of Apollon Wealth Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Apollon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Apollon Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $314k 40k 7.85

More positions owned by Apollon Wealth Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation Put Option (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C Put Option (GOOG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Pgim Etf Tr Tota Retu Bd Etf (PTRB)
Ishares Tr Msci Intl Qualty (IQLT)
Eli Lilly & Co. (LLY)

View all positions for Apollon Wealth Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Bank of America Corporation
Ubs Global Asset Management Americas
Arrowpoint Asset Management
BlackRock
Susquehanna International
Driehaus Capital Management
Citadel Advisors
Morgan Stanley
UBS Group
Tudor Investment Corporation
Marshall Wace

View all funds holding Abcellera Biologics